Global X Autonomous & Electric Vehicles vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Global X Autonomous & Electric Vehicles trades at $30.99 (market cap $357.19M), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 30.2× Global X Autonomous & Electric Vehicles's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Global X Autonomous & Electric Vehicles pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Autonomous & Electric Vehicles for 41 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| DRIV | RDY | |
|---|---|---|
Market Cap | $357.19M | $10.78B |
Volume | 24,175 | 2,724,343 |
Sector | Sector/Thematic | Health |
52-Week High | $42.53 | $15.38 |
52-Week Low | $27.60 | $11.38 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | — | $10.68B |
Dividend Yield | — | 0.65% |
Signals from Pluang's Aura AI — not financial advice
DRIV trades at $32.06, down slightly by 0.06% today. Technical indicators show mixed signals with a bullish overall signal but bearish moving averages. The stock faces resistance at $34 with support at $33. Recent news highlights automotive sector dynamics including hybrid vehicle growth and China's EV ambitions, which could impact DRIV's market positioning.
The outlook for DRIV is cautiously optimistic given sector tailwinds from hybrid and EV adoption, though key financial ratios remain unavailable for fundamental assessment. Risks include oil price volatility and competitive pressures. Analyst sentiment appears balanced with equal buy/sell technical signals, suggesting investors should monitor upcoming earnings for clearer direction.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.
Read more on DRIV →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →